Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
The Team
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
SubB2M CA15-3
SubB2M CA125
Exo-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
8-Dec-2020
Change of Director's Interest Notice - Cumming
3-Dec-2020
Change of Director's Interest Notice - Powell
3-Dec-2020
Change of Director's Interest Notice - Johnston
2-Dec-2020
Final Director's Interest Notice - Helen Fisher
2-Dec-2020
Patent Granted in China for hTERT
1-Dec-2020
Further Detail on BARD1's US Sales Strategy
1-Dec-2020
Trading Halt
1-Dec-2020
Pause in Trading
27-Nov-2020
Results of Meeting
26-Nov-2020
AGM & CEO Presentations and Chairman's Transcript
1
2
3
4
5
Next
